Streetbeat News

Price Targets

GH

Citigroup analyst Patrick Donnelly maintains a Buy rating on Guardant Health (NASDAQ:GH) and raises the price target from $40 to $45.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:23 pm

MDGL

Citigroup analyst David Lebovitz maintains a Buy rating on Madrigal Pharmaceuticals (NASDAQ:MDGL) but lowers the price target from $382 to $371.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:21 pm

SUM

Citigroup analyst Anthony Pettinari maintains a Buy rating on Summit Materials (NYSE:SUM) and raises the price target from $44 to $47.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:20 pm

VMC

Citigroup analyst Anthony Pettinari maintains a Buy rating on Vulcan Materials (NYSE:VMC) but lowers the price target from $297 to $292.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:19 pm

FYBR

Citigroup analyst Michael Rollins maintains a Buy rating on Frontier Communications (NASDAQ:FYBR) and raises the price target from $32 to $35.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:17 pm

LYFT

Citigroup analyst Itay Michaeli maintains a Neutral rating on Lyft (NASDAQ:LYFT) but lowers the price target from $18 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:16 pm

ZI

Citigroup analyst Tyler Radke maintains a Sell rating on ZoomInfo Technologies (NASDAQ:ZI) and lowers the price target from $11 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:15 pm

IAC

Citigroup analyst Ygal Arounian maintains a Buy rating on IAC (NASDAQ:IAC) but lowers the price target from $70 to $66.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 7:13 pm